Trading Lower: Netflix (NFLX), SolarCity (SCTY), Northwest Biotherapeutics, (NWBO), Apple (AAPL)

Shares of Netflix, Inc. (NFLX) are lower by nearly 7% to $104.89 in midday trading on Friday following a Wall Street Journal article discussing that some states are considering taxes on streaming video. The move comes on a big volume too with the issue currently trading more than 23 million shares, compared to the average volume of 18.14 million.

NFLX began trading this morning at $106.11 to currently trade 7 points lower from the prior days close of $112.49. On an intraday basis it has gotten as low as $104.01 and as high as $110.00.

Shares of SolarCity Corporation (SCTY) are lower by more than 10% to $42.25 in mid-day trading on Friday following Jim Chanos’ CNBC comments about the solar energy systems company. According to the Kynikos Associates president & founder, SolarCity is effectively a subprime lender, has no cash flow, no profit, and a lot of debt. He is short on the name.

SolarCity shares have declined 15.14% in the last 4 weeks and 24.36% in the past three months. Over the past 5 trading sessions the stock has lost 6.15%.

Shares of SolarCity Corp are down 33.34% year-over-year and 12.15% since the beginning of the year.

Shares of Northwest Biotherapeutics, Inc. (NWBO) are down $1.54, or 17.34%, at $7.34 on reports the company suspended screening for its brain cancer DCVax drug.

In the last 52 weeks, shares of Bethesda, Maryland-based biotechnology firm have traded between a low of $3.79 and a high of $12.55. Shares are up 40.06% year-over-year and 65.98% year-to-date.

Shares of Apple (AAPL) are lower by 4% to $108.18 on heavy volume in midday trading on Friday, down more 19.59% from the stock’s 52-week high of $134.54 set in Apr 28, 2015. If the iPhone maker’s stock drops more than 20% off the yearly high, it will officially be in bear market territory.

Apple is currently valued at $616.41 billion. The name has a median Wall Street price target of $150 with a high target of $195.

Be the first to comment

Leave a Reply

Your email address will not be published.


*